Delivery Order SPE2DB22D1103-SPE2DB24FTRP1

Award Date 9/17/24
Potential Completion Date 10/8/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award worth $6,461.32 to AmerisourceBergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product Envarsus XR 4 mg tablet, which is a critical medical supply. The contract has a completion date of September 27, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The $1,621.48 order is for the supply of the pharmaceutical product Envarsus XR 1 mg Tablet 100s. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceuticals...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $1,615.33, is for the supply of the specialty medication Envarsus XR 4 mg tablet 100s. The delivery order has an ultimate completion date of April 8, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as a prime...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Envarsus XR 4 mg tablets, a prescription medication, with a ceiling value of $4,845.99 and a completion date of September 25, 2024. The contract is a firm fixed-price, delivery order, with no set-aside designation. Amerisourcebergen is a significant supplier of...
This is a delivery order awarded by the Defense Logistics Agency's Troop Support Medical division to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,216.11 firm-fixed-price contract is for the supply of the prescription drug Envarsus XR 1 MG Tablet, with a performance period ending on May 17, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. Under...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,216.11, is for the supply of Envarsus XR 1 mg tablets, a specialty brand name pharmaceutical medication. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,687.28 firm fixed-price contract is for the delivery of Envarsus XR 4 mg tablets, a transplant medication, to support military and federal healthcare programs. The contract has an ultimate completion date of August 21, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of Envarsus XR 1 mg tablets, with a potential value of $1,216.11 and a period of performance through March 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.66 firm fixed-price contract is for the supply of Envarsus XR 1 mg tablets, a specialty medication. The contract has a period of performance through February 25, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Envarsus XR 1 mg tablets. The $1,216.11 firm fixed-price contract has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities. This specific...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRP1
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,841,195 units of the pharmaceutical product Envarsus XR 1 mg Tablet in 100-count packages. The delivery order has a firm fixed price of $1,621.48 and a completion date of October 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical supplies and medications to support various government agencies and healthcare programs. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal entities, valued up to $999,999,999 and $750,000 respectively, to efficiently deliver essential pharmaceutical and medical products. This delivery order is not associated with a set-aside program.

Generated 12/17/24, 9:36 AM